Mark Dean-Netscher joins Penn Pharma

pharmafile | May 18, 2011 | Appointment | Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development 

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer.

He has more than 20 years experience in the pharmaceutical manufacturing industry and in his new role will manage the operational arm of the South Wales headquartered company.

Mark has held a number of senior industry positions, including heading up Reckitt Benckiser’s global healthcare operation and, most recently, overseeing a significant portion of Catalent’s global production facilities as operations VP, international and Europe.

Advertisement

He said: “I am looking forward to joining this dynamic company where I can employ my extensive experience in leading operations across Europe and the USA, and technical expertise in dosage forms, API manufacture and clinical trials to further grow the business in what will be my first post in Wales.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

Rotzinger launches modular filling and capping platform for over-the-counter products

Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

The Gateway to Local Adoption Series

Latest content